CCR5 and HIV infectious disease: In any case, one would predict that using CCR5 ZFNs [59], C34 based fusion inhibitors [58], or other methods to protect CD4 CAR expressing cells from HIV infection would further potentiate the therapeutic potential of CD4 CAR T cells.